Prehospital use of intravenous verapamil

Verapamil was introduced into a hospital-based urban/rural advanced life support (ALS) system for intravenous (IV) use in patients with symptomatic supraventricular tachyarrhythmias. During this trial period, IV verapamil was given to 24 patients, 12 (50%) of which benefited from its use. IV verapam...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of emergency medicine 1987-05, Vol.5 (3), p.207-210
Hauptverfasser: Shaw, Lewis C., Eitel, David R., Walton, Stacy L., Pollack, Marc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 210
container_issue 3
container_start_page 207
container_title The American journal of emergency medicine
container_volume 5
creator Shaw, Lewis C.
Eitel, David R.
Walton, Stacy L.
Pollack, Marc
description Verapamil was introduced into a hospital-based urban/rural advanced life support (ALS) system for intravenous (IV) use in patients with symptomatic supraventricular tachyarrhythmias. During this trial period, IV verapamil was given to 24 patients, 12 (50%) of which benefited from its use. IV verapamil produced no harmful effects, and there was only one reported adverse effect (nausea) related to its administration. IV verapamil may be useful in the prehospital care of patients with symptomatic supraventricular tachyarrhythmias.
doi_str_mv 10.1016/0735-6757(87)90322-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77524777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0735675787903226</els_id><sourcerecordid>77524777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-a9792efeaa9a0967aa2a690623756f4c7fb63c89314caf8237ef85d4a60f5b8e3</originalsourceid><addsrcrecordid>eNp9kFtLAzEQhYMotVb_gUIfROrDarK57b4IUrxBQR_0OUyzE4zszWS34L93a5c-CgMDM98ZzhxCzhm9YZSpW6q5TJSWepHp65zyNE3UAZkyydMkY5odkukeOSYnMX5RypiQYkImXKRKKT4li7eAn01sfQflvI84b9zc112ADdZNH-cbDNBC5ctTcuSgjHg29hn5eHx4Xz4nq9enl-X9KrE8U10Cuc5TdAiQA82VBkhB5VSlXEvlhNVurbjNcs6EBZcNY3SZLAQo6uQ6Qz4jV7u7bWi-e4ydqXy0WJZQ42DIaC1TobUeQLEDbWhiDOhMG3wF4ccwarYBme33Zvu9ybT5C8ioQXYx3u_XFRZ70ZjIsL8c9xAtlC5AbX3cY1qKocSA3e0wHLLYeAwmWo-1xcIHtJ0pGv-_j1_m4oCi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77524777</pqid></control><display><type>article</type><title>Prehospital use of intravenous verapamil</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Shaw, Lewis C. ; Eitel, David R. ; Walton, Stacy L. ; Pollack, Marc</creator><creatorcontrib>Shaw, Lewis C. ; Eitel, David R. ; Walton, Stacy L. ; Pollack, Marc</creatorcontrib><description>Verapamil was introduced into a hospital-based urban/rural advanced life support (ALS) system for intravenous (IV) use in patients with symptomatic supraventricular tachyarrhythmias. During this trial period, IV verapamil was given to 24 patients, 12 (50%) of which benefited from its use. IV verapamil produced no harmful effects, and there was only one reported adverse effect (nausea) related to its administration. IV verapamil may be useful in the prehospital care of patients with symptomatic supraventricular tachyarrhythmias.</description><identifier>ISSN: 0735-6757</identifier><identifier>EISSN: 1532-8171</identifier><identifier>DOI: 10.1016/0735-6757(87)90322-6</identifier><identifier>PMID: 3426663</identifier><identifier>CODEN: AJEMEN</identifier><language>eng</language><publisher>Philadelphia, PA: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antiarythmic agents ; Biological and medical sciences ; Cardiovascular system ; Emergency Medical Services ; Female ; Humans ; Injections, Intravenous ; Male ; Medical sciences ; Middle Aged ; Monitoring, Physiologic ; Pharmacology. Drug treatments ; Prehospital treatment ; tachyarrhythmias ; tachycardia ; Tachycardia, Supraventricular - drug therapy ; Tachycardia, Supraventricular - physiopathology ; verapamil ; Verapamil - administration &amp; dosage ; Verapamil - therapeutic use</subject><ispartof>The American journal of emergency medicine, 1987-05, Vol.5 (3), p.207-210</ispartof><rights>1987</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-a9792efeaa9a0967aa2a690623756f4c7fb63c89314caf8237ef85d4a60f5b8e3</citedby><cites>FETCH-LOGICAL-c386t-a9792efeaa9a0967aa2a690623756f4c7fb63c89314caf8237ef85d4a60f5b8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0735-6757(87)90322-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7547544$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3426663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shaw, Lewis C.</creatorcontrib><creatorcontrib>Eitel, David R.</creatorcontrib><creatorcontrib>Walton, Stacy L.</creatorcontrib><creatorcontrib>Pollack, Marc</creatorcontrib><title>Prehospital use of intravenous verapamil</title><title>The American journal of emergency medicine</title><addtitle>Am J Emerg Med</addtitle><description>Verapamil was introduced into a hospital-based urban/rural advanced life support (ALS) system for intravenous (IV) use in patients with symptomatic supraventricular tachyarrhythmias. During this trial period, IV verapamil was given to 24 patients, 12 (50%) of which benefited from its use. IV verapamil produced no harmful effects, and there was only one reported adverse effect (nausea) related to its administration. IV verapamil may be useful in the prehospital care of patients with symptomatic supraventricular tachyarrhythmias.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antiarythmic agents</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Emergency Medical Services</subject><subject>Female</subject><subject>Humans</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Monitoring, Physiologic</subject><subject>Pharmacology. Drug treatments</subject><subject>Prehospital treatment</subject><subject>tachyarrhythmias</subject><subject>tachycardia</subject><subject>Tachycardia, Supraventricular - drug therapy</subject><subject>Tachycardia, Supraventricular - physiopathology</subject><subject>verapamil</subject><subject>Verapamil - administration &amp; dosage</subject><subject>Verapamil - therapeutic use</subject><issn>0735-6757</issn><issn>1532-8171</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kFtLAzEQhYMotVb_gUIfROrDarK57b4IUrxBQR_0OUyzE4zszWS34L93a5c-CgMDM98ZzhxCzhm9YZSpW6q5TJSWepHp65zyNE3UAZkyydMkY5odkukeOSYnMX5RypiQYkImXKRKKT4li7eAn01sfQflvI84b9zc112ADdZNH-cbDNBC5ctTcuSgjHg29hn5eHx4Xz4nq9enl-X9KrE8U10Cuc5TdAiQA82VBkhB5VSlXEvlhNVurbjNcs6EBZcNY3SZLAQo6uQ6Qz4jV7u7bWi-e4ydqXy0WJZQ42DIaC1TobUeQLEDbWhiDOhMG3wF4ccwarYBme33Zvu9ybT5C8ioQXYx3u_XFRZ70ZjIsL8c9xAtlC5AbX3cY1qKocSA3e0wHLLYeAwmWo-1xcIHtJ0pGv-_j1_m4oCi</recordid><startdate>19870501</startdate><enddate>19870501</enddate><creator>Shaw, Lewis C.</creator><creator>Eitel, David R.</creator><creator>Walton, Stacy L.</creator><creator>Pollack, Marc</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19870501</creationdate><title>Prehospital use of intravenous verapamil</title><author>Shaw, Lewis C. ; Eitel, David R. ; Walton, Stacy L. ; Pollack, Marc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-a9792efeaa9a0967aa2a690623756f4c7fb63c89314caf8237ef85d4a60f5b8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antiarythmic agents</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Emergency Medical Services</topic><topic>Female</topic><topic>Humans</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Monitoring, Physiologic</topic><topic>Pharmacology. Drug treatments</topic><topic>Prehospital treatment</topic><topic>tachyarrhythmias</topic><topic>tachycardia</topic><topic>Tachycardia, Supraventricular - drug therapy</topic><topic>Tachycardia, Supraventricular - physiopathology</topic><topic>verapamil</topic><topic>Verapamil - administration &amp; dosage</topic><topic>Verapamil - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shaw, Lewis C.</creatorcontrib><creatorcontrib>Eitel, David R.</creatorcontrib><creatorcontrib>Walton, Stacy L.</creatorcontrib><creatorcontrib>Pollack, Marc</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shaw, Lewis C.</au><au>Eitel, David R.</au><au>Walton, Stacy L.</au><au>Pollack, Marc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prehospital use of intravenous verapamil</atitle><jtitle>The American journal of emergency medicine</jtitle><addtitle>Am J Emerg Med</addtitle><date>1987-05-01</date><risdate>1987</risdate><volume>5</volume><issue>3</issue><spage>207</spage><epage>210</epage><pages>207-210</pages><issn>0735-6757</issn><eissn>1532-8171</eissn><coden>AJEMEN</coden><abstract>Verapamil was introduced into a hospital-based urban/rural advanced life support (ALS) system for intravenous (IV) use in patients with symptomatic supraventricular tachyarrhythmias. During this trial period, IV verapamil was given to 24 patients, 12 (50%) of which benefited from its use. IV verapamil produced no harmful effects, and there was only one reported adverse effect (nausea) related to its administration. IV verapamil may be useful in the prehospital care of patients with symptomatic supraventricular tachyarrhythmias.</abstract><cop>Philadelphia, PA</cop><pub>Elsevier Inc</pub><pmid>3426663</pmid><doi>10.1016/0735-6757(87)90322-6</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0735-6757
ispartof The American journal of emergency medicine, 1987-05, Vol.5 (3), p.207-210
issn 0735-6757
1532-8171
language eng
recordid cdi_proquest_miscellaneous_77524777
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adult
Aged
Aged, 80 and over
Antiarythmic agents
Biological and medical sciences
Cardiovascular system
Emergency Medical Services
Female
Humans
Injections, Intravenous
Male
Medical sciences
Middle Aged
Monitoring, Physiologic
Pharmacology. Drug treatments
Prehospital treatment
tachyarrhythmias
tachycardia
Tachycardia, Supraventricular - drug therapy
Tachycardia, Supraventricular - physiopathology
verapamil
Verapamil - administration & dosage
Verapamil - therapeutic use
title Prehospital use of intravenous verapamil
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A01%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prehospital%20use%20of%20intravenous%20verapamil&rft.jtitle=The%20American%20journal%20of%20emergency%20medicine&rft.au=Shaw,%20Lewis%20C.&rft.date=1987-05-01&rft.volume=5&rft.issue=3&rft.spage=207&rft.epage=210&rft.pages=207-210&rft.issn=0735-6757&rft.eissn=1532-8171&rft.coden=AJEMEN&rft_id=info:doi/10.1016/0735-6757(87)90322-6&rft_dat=%3Cproquest_cross%3E77524777%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77524777&rft_id=info:pmid/3426663&rft_els_id=0735675787903226&rfr_iscdi=true